Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential developments into new therapeutic approaches. Current research centers on modifying the underlying causes of MSA. One avenue under investigation involves pharmacological interventions to regulate the activity